Intuitive Surgical, Inc. (NASDAQ:ISRG) was downgraded by investment analysts at Vetr from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday. They currently have a $1,010.56 target price on the medical equipment provider’s stock. Vetr‘s target price indicates a potential upside of 8.96% from the stock’s current price.
A number of other research firms also recently weighed in on ISRG. BidaskClub upgraded Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 23rd. Royal Bank Of Canada upped their target price on Intuitive Surgical from $800.00 to $950.00 and gave the company a “sector perform” rating in a research report on Tuesday. Canaccord Genuity reiterated a “hold” rating and set a $870.00 target price on shares of Intuitive Surgical in a research report on Tuesday, July 11th. Wells Fargo & Company reiterated an “outperform” rating and set a $1,050.00 target price (up from $1,000.00) on shares of Intuitive Surgical in a research report on Wednesday, July 12th. Finally, Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, June 20th. Seven research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $936.33.
Intuitive Surgical (ISRG) opened at 927.47 on Thursday. The company has a market capitalization of $34.17 billion, a PE ratio of 46.75 and a beta of 0.39. The company has a 50-day moving average price of $934.93 and a 200 day moving average price of $803.42. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $974.66.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.41% and a net margin of 27.99%. The firm’s quarterly revenue was up 12.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.62 EPS. On average, equities research analysts forecast that Intuitive Surgical will post $23.59 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/07/22/intuitive-surgical-inc-nasdaqisrg-stock-rating-lowered-by-vetr-inc.html.
In other Intuitive Surgical news, SVP Curet Myriam sold 750 shares of the company’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $930.00, for a total value of $697,500.00. Following the completion of the transaction, the senior vice president now owns 1,428 shares of the company’s stock, valued at approximately $1,328,040. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Jamie Samath sold 48 shares of the company’s stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $850.00, for a total value of $40,800.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,041 shares of company stock valued at $24,493,708. 2.50% of the stock is owned by corporate insiders.
Institutional investors have recently modified their holdings of the company. Gulf International Bank UK Ltd boosted its position in shares of Intuitive Surgical by 2.1% in the first quarter. Gulf International Bank UK Ltd now owns 12,065 shares of the medical equipment provider’s stock worth $9,247,000 after buying an additional 250 shares during the last quarter. Forte Capital LLC ADV boosted its position in shares of Intuitive Surgical by 10.6% in the first quarter. Forte Capital LLC ADV now owns 2,562 shares of the medical equipment provider’s stock worth $1,964,000 after buying an additional 245 shares during the last quarter. Acropolis Investment Management LLC purchased a new position in shares of Intuitive Surgical during the first quarter worth about $115,000. Rathbone Brothers plc boosted its position in shares of Intuitive Surgical by 69.8% in the first quarter. Rathbone Brothers plc now owns 3,040 shares of the medical equipment provider’s stock worth $2,330,000 after buying an additional 1,250 shares during the last quarter. Finally, Chevy Chase Trust Holdings Inc. boosted its position in shares of Intuitive Surgical by 6.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 56,232 shares of the medical equipment provider’s stock worth $43,100,000 after buying an additional 3,416 shares during the last quarter. 97.53% of the stock is owned by institutional investors and hedge funds.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
